Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Reina Watanabe
Observed name:
Watanabe, Reina
Institution:
Yokohama City University
Observed institutions:
Yokohama City University Medical Center,
Kanagawa Cancer Center,
Yokohama City University
OpenAlex ID:
A5113437825
Works
29
Awards
2
Central nervous system involvement in diffuse large B‐cell lymphoma
2010
·
Wataru Yamamoto
, Naoto Tomita
, et al.
·
European Journal Of Haematology
·
86
Central nervous system event in patients with diffuse large B‐cell lymphoma in the rituximab era
2011
·
Naoto Tomita
, Masahiro Yokoyama
, et al.
·
Cancer Science
·
84
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma
2009
·
Reina Watanabe
, Naoto Tomita
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
62
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B ‐cell lymphoma in the rituximab era
2013
·
Reina Watanabe
, Naoto Tomita
, et al.
·
European Journal Of Haematology
·
58
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies
2011
·
Takayoshi Tachibana
, Masatsugu Tanaka
, et al.
·
International Journal of Hematology
·
43
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia
2012
·
Takuya Miyazaki
, Hiroyuki Fujita
, et al.
·
Leukemia Research
·
40
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone
2014
·
Naoto Tomita
, Hirotaka Takasaki
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
25
The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis
2017
·
Naoto Tomita
, Masahiro Yokoyama
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
22
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
2013
·
Reina Watanabe
, Naoto Tomita
, et al.
·
Leukemia Research
·
20
Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions
2010
·
Takuya Miyazaki
, Yohei Kirino
, et al.
·
International Journal of Hematology
·
18
Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study
2014
·
Wataru Yamamoto
, Naoya Nakamura
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
16
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy
2014
·
Yuki Nakajima
, Naoto Tomita
, et al.
·
Medical Oncology
·
15
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy
2014
·
Yuki Nakajima
, Naoto Tomita
, et al.
·
Leukemia Research
·
12
Post-treatment PET–CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass
2014
·
Hirotaka Takasaki
, Wataru Yamamoto
, et al.
·
Indian Journal of Hematology and Blood Transfusion
·
9
PDF
The 3q27 and 18q21 Translocations for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma in the Rituximab Era
2013
·
Reina Watanabe
, Naoto Tomita
, et al.
·
Journal of the Japan Society of the Reticuloendothelial System
·
6
PDF
Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin Lymphoma
2013
·
Yuki Nakajima
, Naoto Tomita
, et al.
·
Blood
·
4
Identification of Bone Marrow Involvement of FL: Comparison of PET-CT and Bone Marrow Biopsy.
2016
·
Yuki Nakajima
, Shin Fujisawa
, et al.
·
Blood
·
2
Amrubicin therapy for platinum-refractory extrapulmonary neuroendocrine carcinoma: Retrospective single-center analysis
2015
·
Yukako Hattori
, Hirotaka Takasaki
, et al.
·
Annals of Oncology
·
2
Maximum Standard Uptake Value at the Biopsy Site during 18F-Fluorodeoxyglucose Positron Emission Tomography Does Not Predict the Proliferation Potential of Tumor Cells in Extranodal Natural Killer/T Cell Lymphoma, Nasal Type
2012
·
Yoshimi Ishii
, Naoto Tomita
, et al.
·
Acta Haematologica
·
2
Central Nervous System Events In Patients with Diffuse Large B-Cell Lymphoma In the Rituximab Era
2010
·
Naoto Tomita
, Masahiro Yokoyama
, et al.
·
Blood
·
1
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy].
2015
·
Hideyuki Koharazawa
, Reina Watanabe
, et al.
·
PubMed
No Outcome Differences Were Observed Between Supra-Diaphragmatic and Infra-Diaphragmatic Lesions in Limited-Stage Diffuse Large B Cell Lymphoma Treated with R-CHOP Therapy, Whereas the Presence of Gastro-Intestinal Lesions Was Associated with a Favorable Prognosis
2014
·
Yuki Nakajima
, Naoto Tomita
, et al.
·
Blood
Efficacy of Rasburicase for the Prophylaxis of Tumor Lysis Syndrome in Non-Hodgkin Lymphoma Patients
2014
·
Hiroyuki Takahashi
, Hirotaka Takasaki
, et al.
·
Annals of Oncology
PDF
Peripheral Blood Lymphocyte/Monocyte Ratio At 6 Months After Remission As a Predictor Of Relapse After R-CHOP Therapy In Patients With Diffuse Large B-Cell Lymphoma
2013
·
Reina Watanabe
, Naoto Tomita
, et al.
·
Blood
Serum Ferritin Level As a Prognostic Marker For Peripheral T-Cell Lymphoma.
2013
·
Satoshi Koyama
, Naoto Tomita
, et al.
·
Blood
Show more works
View as search
Works count:
29
Citation count:
527
H-index:
12
I10-index:
13
Year
Topic
Type
